Ethanol induced delayed cellular protection in mouse cardiac myocytes: Role of inducible nitric oxide synthase

Polish Journal of Pharmacology

Volumn 55, Issue 4, 2003, Pages 595-602

  Nayeem, Mohammed A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Alcohol; Delayed cellular protection; Pharmacological preconditioning; Sustained simulated ischemia

Indexed keywords

ALCOHOL; CREATINE KINASE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; CULTURE MEDIUM; DOSE TIME EFFECT RELATION; HEART CELL CULTURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HYPOTHESIS; MOUSE; MOUSE STRAIN; NONHUMAN; STATISTICAL ANALYSIS;

ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; TIME FACTORS;

EID: 0141613652     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bastianetto S., Zheng W.H., Quirion R.: Neuroprotective abilities of resveratrol and other red wine constituents against nitric-oxide-related toxicity in cultured hippocampal neurons. Brit. J. Pharmacol., 2001, 131, 711-720.
2. Baxter G.F., Marber M.S., Patel V.C., Yellon D.M.: Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation, 1994, 90, 2993-3000.
3. 1-receptor activation in the rabbit. J. Cardiovasc. Pharmacol., 1997, 29, 631-638.
4. Chen C.K., Pace-Asciak C.R.: Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen. Pharmacol., 1996, 27, 363-366.
5. Currie R.W., Ross B.M., David T.A.: Induction of heat shock response in rat model, rat heart, creatine kinase and protein synthesis after subsequent hyperthermic treatment. Cardiovasc. Res., 1990, 14, 87-93.
6. Das D.K., Sato M., Ray P.S., Maulik G., Engelman R.M., Bertelli A.A.E., Bertelli A.: Cardioprotection with red wine: role of polyphenolic antioxidants. Drug Exp. Clin. Res., 1999, 25, 115-120.
7. Flogel U., Decking U.K.M., Godecke A., Schrader J.: Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: a study in endothelial NO synthase knockout mice. J. Mol. Cell. Cardiol., 1999, 31, 827-836.
8. Fuchs C.S., Stampfer M.J., Colditz G.A., Giovannucci E.L., Manson J.E., Kawachi I., Hunter D.J., Hankinson S.E., Hennekens C.H., Rosner B., Speizer F.E., Willett W.C.: Alcohol consumption and mortality among women. N. Engl. J. Med., 1995, 332, 1245-1250.
9. Giovannini L., Migliori M., Longoni B.M., Das D.K., Bertelli A.A.E., Panichi V., Filippi C., Bertelli A.: Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J. Cardiovasc. Pharmacol., 2001, 37, 262-270.
10. Guo Y., Jones W.K., Xuan Y.-T., Tang X.-L., Bao W., Wu W.-J., Han H., Laubach V.E., Ping P., Yang Z., Qui Y., Bolli R.: The late phase ischemic preconditioning is abrogated by targeted disruption of iNOS gene. Proc. Nat. Acad. Sci. USA, 1999, 96, 11507-11512.
11. Guo Y., Wu Y.J., Qiu X., Tang Z., Yang., Bolli R.: Demonstration of an early and a late phase of ischemic preconditioning in mice. Amer. J. Physiol., 1998, 275, H1375-H1387.
12. Hattori R., Otani H., Maulik N., Das D.K.: Pharmacological preconditioning with resveratrol: role of nitric oxide. Amer. J. Physiol.-Heart Circ. Phy., 2002, 282, H1988-1995.
13. Headrick J.P.: Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine. J. Mol. Cell. Cardiol., 1996, 28, 1227-1240.
14. Hung L.M., Chen J.K., Hunag S.S., Lee R.S., Su M.J.: Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res., 2000, 47, 549-555.
15. Imamura G., Bertelli A.A., Bertelli A., Otani H., Maulik N., Das D.K.: Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Amer. J. Physiol.-Heart Circ. Phy., 2002, 282, H1996-H2003.
16. Klatsky A.L., Armstrong M.A., Friedman G.D.: Risk of cardiovascular mortality in alcohol drinkers, exdrinkers and nondrinkers. Amer. J. Cardiol., 1990, 66, 1237-1242.
17. Lawson C.S., Downey J.M.: Preconditioning: state of the art myocardial protection. Cardiovasc. Res., 1993, 27, 542-550.
18. Maldonado C., Qiu Y, Tang X.L., Cohen M.V., Auchampach J., Bolli R.: Role of adenosine receptors in late preconditioning against myocardial stunning in conscious rabbits. Amer. J. Physiol., 1997, 273, H1324-H1332.
19. Marber M.S., Latchmann D.S., Walker J.M., Yellon D.M.: Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation, 1993, 88, 1264-1272.
20. Maulik N., Engelman D.T., Watanabe M., Engelman R.M., Maulik G., Cordis G.A., Das D.K.: Nitric oxide signaling in ischemic heart. Cardiovasc. Res., 1995, 30, 593-601.
21. Murry C.E., Jennings R.B., Reimer K.A.: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 1986, 74, 1124-1136.
22. Nayeem M.A., Hess M.L., Qian Y., Loesser K.E., Kukreja R.C.: Delayed preconditioning of cultured adult rat cardiac myocytes. Role of 70 and 90 kD heat stress proteins in protection against lethal cellular injury. Amer. J. Physiol., 1997, 42, H861-H868.
23. ATP channels. Naunyn-Schmied. Arch. Pharmacol., 2003, 367, 219-226.
24. 1 adenosine receptor in porcine coronary smooth muscle cells. Pol. J. Pharmacol., 2002, 54, 443-453.
25. Nayeem M.A., Weixi Q., Hu Q., Mustafa S.J.: Hyperthermia induces late cross-tolerance against simulated ischemia in adult murine cultured cardiac myocytes. J. Mol. Cell. Cardiol., 2000, 32, A47.
26. Ray P.S., Maulik G., Cordis G.A., Bertelli A.A.E., Bertelli A., Das D.K.: The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radical Biol. Med., 1999, 27, 160-169.
27. Reimer K.A., Murry C.E, Yamasawa I, Hill M.L., Jennings R.B.: Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Amer. J. Physiol., 1986, 251, H1306-H1315.
28. Rimm E.B., Giovannucci E.L., Willett W.C., Colditz G.A., Ascherio A., Rosner B., Stampfer M.J.: Prospective study of alcohol consumption and risk of coronary disease in men. Lancet, 1991, 338, 464-468.
29. Wang Y., Marsden P.A.: Nitric oxide synthases: gene structure and regulation. Adv. Pharmacol., 1995, 34, 71-90.
30. Wannamethee G., Whincup P.H., Shaper A.G., Walker M., MacFarlane P.W.: Factors determining case fatality in myocardial infarction "who dies in a heart attack"? Brit. Heart J., 1995, 74, 324-331.
31. Yellon D.M., Baxter G.F., Garcia-Dorado D., Heusch G., Sumeray M.S.: Ischaemic preconditioning: present position and future directions. Cardiovasc. Res., 1998, 37, 21-33.